Kazia Therapeutics (KZIA) Change in Account Payables (2016 - 2022)
Kazia Therapeutics (KZIA) posted Change in Account Payables of -$401671.6 for Q4 2022, down 134.28% on a QoQ basis from $1.2 million in Q4 2021, and down 134.28% year-over-year from $1.2 million in Q4 2021.
Kazia Therapeutics (KZIA) Change in Account Payables (2016 - 2022) Analysis & Trends
Kazia Therapeutics' Change in Account Payables history runs 4 years deep, the most recent figure standing at -$401671.6 for Q4 2022.
- Quarterly Change in Account Payables fell 134.28% year-over-year to -$401671.6 in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $1.1 million (down 31.22% YoY) and the FY2025 annual result came in at -$3.2 million, down 144.8% from the prior year.
- Change in Account Payables was -$401671.6 for Q4 2022 at Kazia Therapeutics, down from $1.2 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $1.2 million in Q4 2021 and bottomed at -$448508.9 in Q4 2020.
- A 3-year average of $107171.8 and a median of -$401671.6 in 2022 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2021 — Change in Account Payables soared 361.24% — and 2022, when it slumped 134.28%.
- Kazia Therapeutics' Change in Account Payables stood at -$448508.9 in 2020, then surged by 361.24% to $1.2 million in 2021, then slumped by 134.28% to -$401671.6 in 2022.
- Business Quant data shows KZIA's Change in Account Payables at -$401671.6 in Q4 2022, $1.2 million in Q4 2021, and -$448508.9 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,440.76 Bn | 66,440.47 Bn | - | - |
| 2 | Nanobiotix | 1,909.20 Bn | 1,909.14 Bn | - | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 4 | BeOne Medicines | 468.28 Bn | 463.49 Bn | 1.35 Bn | -42.19 Mn |
| 5 | Vertex Pharmaceuticals | 122.49 Bn | 115.24 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 70.26 Bn | 61.51 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.88 Bn | 62.88 Bn | - | - |
| 8 | Argenx Se | 55.67 Bn | 50.48 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.37 Bn | 34.36 Bn | 959.66 Mn | - |
| 10 | Kazia Therapeutics | 19.14 Bn | 19.14 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -401,671.59 |
| Dec 31, 2022 | -401,671.59 |
| Dec 31, 2021 | 1.17 Mn |
| Dec 31, 2021 | 1.17 Mn |
| Dec 31, 2020 | -448,508.89 |
| Dec 31, 2020 | -448,508.89 |
| Dec 31, 2016 | 801,677.77 |
| Dec 31, 2016 | 801,677.77 |